👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

S&P 500 Rises 1%; US Wholesale Inventories Fall In August

Published 10/10/2023, 17:04
Updated 10/10/2023, 18:10
© Reuters.  S&P 500 Rises 1%; US Wholesale Inventories Fall In August
EUR/USD
-
US500
-
GC
-
HG
-
SI
-
CL
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Tuesday.

The Dow traded up 0.81% to 33,876.62 while the NASDAQ rose 1.23% to 13,650.54. The S&P 500 also rose, gaining, 1.10% to 4,383.17.

Check This Out: Walgreens Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Leading and Lagging Sectors

Consumer discretionary shares rose by 1.4% on Tuesday.

In trading on Tuesday, energy shares fell by around 0.1%.

Top Headline

U.S. wholesale inventories fell 0.1% month-over-month in August.

Equities Trading UP

SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares shot up 99% to $3.3841 after the company announced it secured a majority stake in True Gold Consortium.

Shares of Intrusion Inc. (NASDAQ: INTZ) got a boost, shooting 46% to $0.5094. Intrusion has been awarded a $5 million agreement with a large telecommunications provider to provide Intrusion Shield support for its data centers.

Startek, Inc. (NYSE: SRT) shares were also up, gaining 29% to $4.2191 as the company agreed to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash.

Equities Trading DOWN

Akero Therapeutics, Inc. (NASDAQ: AKRO) shares dropped 66% to $16.72 after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate efruxifermin.

Shares of Athersys, Inc. (NASDAQ: ATHX) were down 47% to $0.16 after the company reported interim analysis results of MASTERS-2 clinical study with multistem in ischemic stroke and signed a Memorandum of Understanding for global ARDS license with Healios.

Ventyx Biosciences, Inc. (NASDAQ: VTYX) was down, falling 24% to $22.95 after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active ulcerative colitis.

Also Check This Out: Check Out 3 High-Yielding Dividend Stocks In Energy Sector From Wall Street's Most Accurate Analysts

Commodities

In commodity news, oil traded down 1% to $85.53 while gold traded up 0.3% at $1,869.50.

Silver traded up 0.2% to $21.96 on Tuesday while copper fell 0.9% to $3.6145.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 1.8% London’s FTSE 100 gained 1.74% while Spain’s IBEX 35 Index rose 2.3% The German DAX rose 1.86% French CAC 40 climbed 1.84%, while Italy’s FTSE MIB Index gained 2.3%.

Industrial production in Italy rose 0.2% month-over-month in August following a revised 0.9% fall in July. Retail sales in the UK rose 2.8% from a year ago in September.

Asia Pacific Markets

Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 2.43%, China’s Shanghai Composite Index falling 0.70% and Hong Kong’s Hang Seng Index gaining 0.84%. India’s S&P BSE Sensex, meanwhile, rose 0.9%.

Japan's current account surplus narrowed to JPY 2.280 trillion in August from JPY 2.772 trillion in the prior month, compared to market estimates of JPY 3.091 trillion.

Economics

The NFIB Small Business Optimism Index fell for a second month to a reading of 90.8 in September from 91.3 in the prior month.

U.S. wholesale inventories fell 0.1% month-over-month in August.

Now Read This: Top 3 Tech And Telecom Stocks You May Want To Dump In October

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.